<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(2)</volume><submitter>Meesilpavikkai K</submitter><pubmed_abstract>The STAT3 is an important regulator in a wide range of different cell types. Human &lt;i>STAT3&lt;/i> variants are associated with several immune dysregulation diseases. The current study investigated the clinical, genetic, and immunobiological data obtained from a family with novel heterozygous &lt;i>STAT3&lt;/i> variants located at p.Y360C of the DNA binding domain. The clinical manifestations of these patients include autoimmunity, immunodeficiency, and postnatal growth defects. Broad STAT3 regulated cells including patient primary immune cells and HEK293 cells harboring the variant were assessed. Remarkably high levels of STAT3-regulated cytokines were detected in the sera of the patients. STAT3 nuclear binding and STAT3 activity were higher in STAT3-transduced HEK293 cells containing the p.Y360C </pubmed_abstract><journal>Immune network</journal><pagination>e18</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12056293</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel &amp;lt;i&amp;gt;STAT3&amp;lt;/i&amp;gt; Y360C Gain-of-function Variant Underlies Immune Dysregulation and Aberrancy in Mitochondrial Dynamics.</pubmed_title><pmcid>PMC12056293</pmcid><pubmed_authors>Martin van Hagen P</pubmed_authors><pubmed_authors>Milanese C</pubmed_authors><pubmed_authors>Mastroberardino PG</pubmed_authors><pubmed_authors>Dik WA</pubmed_authors><pubmed_authors>Dalm VASH</pubmed_authors><pubmed_authors>Bakker M</pubmed_authors><pubmed_authors>van der Spek PJ</pubmed_authors><pubmed_authors>Kaikaew K</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>IJspeert H</pubmed_authors><pubmed_authors>Vasic P</pubmed_authors><pubmed_authors>Hirankarn N</pubmed_authors><pubmed_authors>Schrijver B</pubmed_authors><pubmed_authors>Meesilpavikkai K</pubmed_authors><pubmed_authors>de Bie M</pubmed_authors><pubmed_authors>Suratannon N</pubmed_authors><pubmed_authors>Swagemakers SMA</pubmed_authors><pubmed_authors>Schliehe C</pubmed_authors><pubmed_authors>Kaiser FMP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel &amp;lt;i&amp;gt;STAT3&amp;lt;/i&amp;gt; Y360C Gain-of-function Variant Underlies Immune Dysregulation and Aberrancy in Mitochondrial Dynamics.</name><description>The STAT3 is an important regulator in a wide range of different cell types. Human &lt;i>STAT3&lt;/i> variants are associated with several immune dysregulation diseases. The current study investigated the clinical, genetic, and immunobiological data obtained from a family with novel heterozygous &lt;i>STAT3&lt;/i> variants located at p.Y360C of the DNA binding domain. The clinical manifestations of these patients include autoimmunity, immunodeficiency, and postnatal growth defects. Broad STAT3 regulated cells including patient primary immune cells and HEK293 cells harboring the variant were assessed. Remarkably high levels of STAT3-regulated cytokines were detected in the sera of the patients. STAT3 nuclear binding and STAT3 activity were higher in STAT3-transduced HEK293 cells containing the p.Y360C </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-04-18T03:22:17.351Z</modification><creation>2026-04-18T03:11:58.947Z</creation></dates><accession>S-EPMC12056293</accession><cross_references><pubmed>40342844</pubmed><doi>10.4110/in.2025.25.e18</doi></cross_references></HashMap>